Skip Navigation
ChemIDplus Lite•Browse•Advanced

Substance Name: Trastuzumab [USAN:INN:BAN]
RN: 180288-69-1
UNII: P188ANX8CK

Note

  • A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.

Molecular Formula

  • Unspecified
 

Classification Codes

  • Antineoplastic Agents
  • Antineoplastic Agents, Immunological

Names and Synonyms

Name of Substance

  • Trastuzumab
  • Trastuzumab [USAN:INN:BAN]

MeSH Heading

  • Trastuzumab

Synonyms

  • 212Pb-TCMC-Trastuzumab
  • Herceptin
  • HSDB 8142
  • Immunoglobulin G 1 (human-mouse monoclonal rhuMab HER2gamma1-chain antihuman p185(sup c-erbB2) receptor), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer
  • MYL-1401O
  • Ogivri
  • PF 05280014
  • rhumbAb 4D5
  • Thiomab
  • Trastuzumab
  • Trastuzumab-dkst
  • Trastuzumab-dkst [Olgivri]
  • UNII-P188ANX8CK

Systematic Name

  • Immunoglobulin G1, anti-(human p185neu receptor) (human-mouse monoclonal rhuMab HER2 gamma1-chain), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer

Registry Numbers

CAS Registry Number

  • 180288-69-1

FDA UNII

  • P188ANX8CK

System Generated Number

  • 0180288691